ClearBridge Investments’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,000
Closed -$17K 1021
2020
Q1
$17K Hold
3,000
﹤0.01% 902
2019
Q4
$32K Hold
3,000
﹤0.01% 910
2019
Q3
$38K Hold
3,000
﹤0.01% 856
2019
Q2
$51K Hold
3,000
﹤0.01% 819
2019
Q1
$54K Sell
3,000
-416
-12% -$7.19K ﹤0.01% 829
2018
Q4
$43K Hold
3,416
﹤0.01% 863
2018
Q3
$73K Hold
3,416
﹤0.01% 860
2018
Q2
$71K Sell
3,416
-569
-14% -$12.8K ﹤0.01% 805
2018
Q1
$100K Hold
3,985
﹤0.01% 780
2017
Q4
$76K Hold
3,985
﹤0.01% 805
2017
Q3
$74K Hold
3,985
﹤0.01% 794
2017
Q2
$70K Buy
3,985
+41
+1% +$782 ﹤0.01% 804
2017
Q1
$73K Hold
3,944
﹤0.01% 837
2016
Q4
$81K Buy
3,944
+11
+0.3% +$277 ﹤0.01% 841
2016
Q3
$118K Hold
3,933
﹤0.01% 801
2016
Q2
$106K Buy
3,933
+492
+14% +$11.1K ﹤0.01% 813
2016
Q1
$65K Buy
3,441
+181
+6% +$3.45K ﹤0.01% 858
2015
Q4
$101K Hold
3,260
﹤0.01% 865
2015
Q3
$70K Hold
3,260
﹤0.01% 932
2015
Q2
$124K Sell
3,260
-120
-4% -$3.94K ﹤0.01% 882
2015
Q1
$106K Buy
3,380
+380
+13% +$12.9K ﹤0.01% 895
2014
Q4
$105K Hold
3,000
﹤0.01% 912
2014
Q3
$63K Hold
3,000
﹤0.01% 942
2014
Q2
$65K Buy
+3,000
New +$63.1K ﹤0.01% 950

Other funds holding MGNX

ClearBridge Investments's MGNX Position: Q2 2020 in Review

ClearBridge Investments sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 3,000 shares — an estimated $17K sold.

ClearBridge Investments first reported a position in MGNX in Q2 2014 and held it in 24 quarters. The position peaked at $124K in Q2 2015. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

  • ClearBridge Investments reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
  • ClearBridge Investments sold 3,000 MacroGenics shares in Q2 2020, an estimated $17K.
  • ClearBridge Investments first reported a position in MacroGenics in Q2 2014 and held it in 24 quarters.
  • ClearBridge Investments's MacroGenics position peaked at $124K in Q2 2015.
  • 137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on ClearBridge Investments's 13F filing for Q2 2020, filed 14 Aug 2020.